James Moe, PHD, MBA

James Moe, Ph.D., MBA, President and CEO, Oligomerix, Inc. - Dr. Moe has 20+ years industrial experience having held senior management experience in product development working on international teams in both early and late stage diagnostic, biotechnology and biopharmaceutical companies including Gene-Trak/Amoco Technology Ventures/Vysis, bioMerieux, and Mosaic Technologies. Prior to founding Oligomerix, he was Director of Product Development at Pyrosequencing, Senior Molecular Biologist at Spire Biomedical, and Director of Product Development at Q-RNA; Inc. Dr. Moe received his Ph.D. degree in Molecular Biology/Molecular Biophysics from Wesleyan University, did his postdoctoral studies at Vanderbilt University in the Center for Molecular Toxicology, and has an MBA degree with a concentration in entrepreneurial studies from Boston University.